Human Chorionic Gonadotropin Market (Treatments: Female Infertility, Oligospermia, Cryptorchidism & Others; Technology: Natural Source Extraction & Recombinant DNA Technology): Growth, Future Prospects and Competitive Analysis, 2016-2022, the human chorionic gonadotropin market was valued at USD346.3 Mn in 2015, and is expected to reach USD533.7Mn by 2022, expanding at a CAGR of 6% from 2016 to 2022.
Browse Full Report Visit - http://www.acutemarketreports.com/report/human-chorionic-gonadotropin-market
Market Insights
Infertility treatment in both males and females is the major treatment area whereHCG is commonly administered. Growing incidence of infertility in women,contributed by increased maternity age, lifestyle effects and others, hormonaldysfunctions in men and growing incidence of oligospermia are the key factors thathave supported the demand for HCG drugs in the market. The demand for HCG issteady in developed markets of Europe and North America. On the other hand,growing awareness in general population and development of healthcareinfrastructure are supporting the growth in demand for HCG drugs in emergingmarkets.
HCG supports the normal development of egg in ovary and stimulates egg release during ovulation. It is also used for infertility treatment in women and to augmentsperm count in men. Young boys with undescended testicles are also administeredHCG treatment. Hugh prevalence of both male and female infertility issues,expanding incidence of low sperm count and sperm density in men are is the keyfactor driving the HCG drugs market. A majority of the products currently availablein the market are natural source, i.e. urine derived HCG. However, in view of batchto batch inconsistency in product purity and requirement of large amount of urinehas resulted in emergence of recombinant production technology.
North America is expected to be the largest and most potential regional market forhuman chorionic gonadotropin. North America constitutes regional markets of U.S.and Canada, the rising incidence of infertility cases, lifestyle effects and others,hormonal dysfunctions in men and women are the major driver for the growth ofthe global human chorionic gonadotropin market. Asia-Pacific is the expected to bethe most potential regional market for human chorionic gonadotropin market by2022. Over the next six years, the growth of the market in the Asia-Pacific region islikely to be centered in Japan, South Korea, China, and India.The key players in human chorionic gonadotropin market are EMD Serono, Inc.,Ferring B.V., Merck & Co., Inc., Bristol Myers Squibb Company and Fresenius KabiUSA, LLC.
Infertility treatment in both males and females is the major treatment area whereHCG is commonly administered. Growing incidence of infertility in women,contributed by increased maternity age, lifestyle effects and others, hormonaldysfunctions in men and growing incidence of oligospermia are the key factors thathave supported the demand for HCG drugs in the market. The demand for HCG issteady in developed markets of Europe and North America. On the other hand,growing awareness in general population and development of healthcareinfrastructure are supporting the growth in demand for HCG drugs in emergingmarkets.
HCG supports the normal development of egg in ovary and stimulates egg release during ovulation. It is also used for infertility treatment in women and to augmentsperm count in men. Young boys with undescended testicles are also administeredHCG treatment. Hugh prevalence of both male and female infertility issues,expanding incidence of low sperm count and sperm density in men are is the keyfactor driving the HCG drugs market. A majority of the products currently availablein the market are natural source, i.e. urine derived HCG. However, in view of batchto batch inconsistency in product purity and requirement of large amount of urinehas resulted in emergence of recombinant production technology.
North America is expected to be the largest and most potential regional market forhuman chorionic gonadotropin. North America constitutes regional markets of U.S.and Canada, the rising incidence of infertility cases, lifestyle effects and others,hormonal dysfunctions in men and women are the major driver for the growth ofthe global human chorionic gonadotropin market. Asia-Pacific is the expected to bethe most potential regional market for human chorionic gonadotropin market by2022. Over the next six years, the growth of the market in the Asia-Pacific region islikely to be centered in Japan, South Korea, China, and India.The key players in human chorionic gonadotropin market are EMD Serono, Inc.,Ferring B.V., Merck & Co., Inc., Bristol Myers Squibb Company and Fresenius KabiUSA, LLC.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/medical-devices-market
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Human Chorionic Gonadotropin Market, by Therapeutic Area, 2015 (USD Mn)
2.2 Global Human Chorionic Gonadotropin Market, by Technology, 2015 (USD Mn)
2.3 Global Human Chorionic Gonadotropin Market, by Therapeutic Area Market, by Geography, 2015 (Value %)
2.1 Global Human Chorionic Gonadotropin Market, by Therapeutic Area, 2015 (USD Mn)
2.2 Global Human Chorionic Gonadotropin Market, by Technology, 2015 (USD Mn)
2.3 Global Human Chorionic Gonadotropin Market, by Therapeutic Area Market, by Geography, 2015 (Value %)
Chapter 3 Global Hematopoietic Stem Cells Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 High Infertility Prevalence Worldwide
3.3 Market Restraints
3.3.1 Availability of Substitutes
3.4 Market Opportunities
3.4.1 Demand for Recombinant HCG
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Human Chorionic Gonadotropin Market, by Key Players
3.1 Overview
3.2 Market Drivers
3.2.1 High Infertility Prevalence Worldwide
3.3 Market Restraints
3.3.1 Availability of Substitutes
3.4 Market Opportunities
3.4.1 Demand for Recombinant HCG
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Human Chorionic Gonadotropin Market, by Key Players
Chapter 4 Global Human Chorionic Gonadotropin Market Analysis, By Treatment
4.1 Overview
4.2 Female Infertility Treatment
4.3 Oligospermia Treatment
4.4 Cryptorchidism Treatment
4.5 Others
4.1 Overview
4.2 Female Infertility Treatment
4.3 Oligospermia Treatment
4.4 Cryptorchidism Treatment
4.5 Others
Chapter 5 Global Human Chorionic Gonadotropin Market Analysis, By Technology
5.1 Overview
5.2 Natural Source Extraction
5.3 Recombinant DNA Technology
5.1 Overview
5.2 Natural Source Extraction
5.3 Recombinant DNA Technology
Chapter 6 Global Human Chorionic Gonadotropin Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East and Africa
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East and Africa
To Get Complete Report @ http://www.acutemarketreports.com/report/human-chorionic-gonadotropin-market
Chapter 7 Company Profiles
7.1 Ferring B.V.
7.1.1 Ferring B.V.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Bristol Mayer Squibb Company
7.2.1 Bristol Mayer Squibb Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 EMD Serono, Inc.
7.3.1 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 Fresenius Kabi USA, LLC
7.4.1 Fresenius Kabi USA, LLC: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.1 Ferring B.V.
7.1.1 Ferring B.V.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Bristol Mayer Squibb Company
7.2.1 Bristol Mayer Squibb Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 EMD Serono, Inc.
7.3.1 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 Fresenius Kabi USA, LLC
7.4.1 Fresenius Kabi USA, LLC: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Latest Reports :
http://www.acutemarketreports.com/report/3d-bioprinters-market
http://www.acutemarketreports.com/report/3d-bioprinters-market
Our Blog :- http://www.newzmarket.com/
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
